PHS 2023 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) (Discontinued)

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This NIH omnibus solicitation for Small Business Technology Transfer (STTR) grants encourages small businesses to collaborate with research institutions on early-stage biomedical research and development projects with commercialization potential. It supports innovative solutions to critical needs in healthcare and biomedical science.

PHS 2023-2: Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42], Clinical Trial Not Allowed) is sponsored by Department of Health and Human Services (HHS) - National Institutes of Health (NIH). This omnibus solicitation invites Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that collaborate with research institutions to develop innovative technologies.

PHS 2023 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation supports small businesses in partnership with nonprofit research institutions (e. g. , universities) to engage in cooperative research and development with strong potential for commercialization.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) is sponsored by NIH (part of HHS). This program supports small businesses in partnership with U.S. research institutions for federal research and development with strong commercialization potential in public health, medicine, and social services. It may include projects addressing health-related social needs like non-medical transportation.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) is sponsored by National Institutes of Health (NIH). This omnibus solicitation offers non-dilutive funding to small businesses for early-stage research and development projects in collaboration with research institutions. It supports innovative solutions in alignment with NIH's mission areas, particularly in healthcare and biomedical science.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) (Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI) / National Institutes of Health (NIH). This omnibus solicitation encourages Small Business Technology Transfer (STTR) grant applications for investigator-initiated projects across a broad spectrum of topic areas relevant to the mission of the NIH.

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC). Similar to SBIR, the STTR program focuses on funding research in the R&D arena, specifically encouraging partnerships between small businesses and non-profit research institutions to stimulate technological innovation.

PHS-2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). This omnibus solicitation facilitates research and development collaborations between small businesses and research institutions. It aims to stimulate technological innovation and increase private sector commercialization of technology developed through federal R&D funding. Maternal and child health equity projects involving such collaborations would be relevant.

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This program supports cooperative research and development between small businesses and non-profit research institutions. It funds early-stage biomedical commercialization, including health-related research and development.